My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 692

    1.

    Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.

    Schousboe ML, Rajakaruna RS, Salanti A, Hapuarachchi HC, Galappaththy GN, Bygbjerg IC, Amerasinghe PH, Konradsen F, Alifrangis M.

    Malar J. 2007 Mar 9;6:28.PMID: 17349045 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.

    Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, Jahevitra M, Picot S, Ménard D.

    Malar J. 2008 Feb 26;7:35.PMID: 18302746 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.

    Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.

    Malar J. 2008 Jul 1;7:115.PMID: 18590577 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.

    Barnadas C, Musset L, Legrand E, Tichit M, Briolant S, Fusai T, Rogier C, Bouchier C, Picot S, Ménard D.

    Am J Trop Med Hyg. 2009 Jul;81(1):19-22.PMID: 19556560 [PubMed - indexed for MEDLINE]Related articles

    5.

    Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East.

    Zakeri S, Motmaen SR, Afsharpad M, Djadid ND.

    Malar J. 2009 Jan 28;8:20.PMID: 19175936 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.

    Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH.

    Am J Trop Med Hyg. 2006 Feb;74(2):198-204.PMID: 16474070 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.

    Imwong M, Pukrittayakamee S, Cheng Q, Moore C, Looareesuwan S, Snounou G, White NJ, Day NP.

    Antimicrob Agents Chemother. 2005 Oct;49(10):4393-5.PMID: 16189131 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.

    Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q.

    Am J Trop Med Hyg. 2006 Oct;75(4):617-21.PMID: 17038682 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase.

    Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH.

    Malar J. 2008 Apr 28;7:72.PMID: 18442404 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology.

    Alifrangis M, Enosse S, Pearce R, Drakeley C, Roper C, Khalil IF, Nkya WM, Rønn AM, Theander TG, Bygbjerg IC.

    Am J Trop Med Hyg. 2005 Feb;72(2):155-62.PMID: 15741552 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.

    Mbugi EV, Mutayoba BM, Malisa AL, Balthazary ST, Nyambo TB, Mshinda H.

    Malar J. 2006 Oct 31;5:94.PMID: 17076899 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.

    Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T.

    Acta Trop. 2003 Mar;85(3):363-73.PMID: 12659974 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.

    Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, Snounou G.

    Antimicrob Agents Chemother. 2001 Nov;45(11):3122-7.PMID: 11600366 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.

    Biswas S.

    J Postgrad Med. 2004 Jan-Mar;50(1):17-20.PMID: 15047993 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.

    Zakeri S, Afsharpad M, Raeisi A, Djadid ND.

    Malar J. 2007 Nov 13;6:148.PMID: 17999755 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.

    Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM.

    Antimicrob Agents Chemother. 2002 Dec;46(12):3947-53.PMID: 12435700 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.

    Schunk M, Kumma WP, Miranda IB, Osman ME, Roewer S, Alano A, Löscher T, Bienzle U, Mockenhaupt FP.

    Malar J. 2006 Jul 3;5:54.PMID: 16817953 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Antifolates can have a role in the treatment of Plasmodium vivax.

    Hawkins VN, Joshi H, Rungsihirunrat K, Na-Bangchang K, Sibley CH.

    Trends Parasitol. 2007 May;23(5):213-22. Epub 2007 Mar 26. Review.PMID: 17368986 [PubMed - indexed for MEDLINE]Related articles

    19.

    Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates.

    Brega S, de Monbrison F, Severini C, Udomsangpetch R, Sutanto I, Ruckert P, Peyron F, Picot S.

    Antimicrob Agents Chemother. 2004 Jul;48(7):2581-7.PMID: 15215112 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.

    Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B.

    J Infect Dis. 2008 Aug 1;198(3):409-17.PMID: 18582193 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk